Atai Life Sciences Stock Performance
ATAI Stock | USD 1.62 0.00 0.00% |
On a scale of 0 to 100, ATAI Life holds a performance score of 3. The firm owns a Beta (Systematic Risk) of 1.02, which signifies a somewhat significant risk relative to the market. ATAI Life returns are very sensitive to returns on the market. As the market goes up or down, ATAI Life is expected to follow. Please check ATAI Life's sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether ATAI Life's current price history will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ATAI Life Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, ATAI Life demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Insider Trading | 12/31/2024 |
2 | Acquisition by Gerd Kochendoerfer of 1450000 shares of ATAI Life at 1.6 subject to Rule 16b-3 | 01/02/2025 |
3 | Acquisition by Rao Srinivas of 2340000 shares of ATAI Life at 1.75 subject to Rule 16b-3 | 01/07/2025 |
4 | Acquisition by Christian Angermayer of 64000 shares of ATAI Life subject to Rule 16b-3 | 01/08/2025 |
5 | Atai Life Sciences says Srinivas Rao assumes role of sole CEO | 01/10/2025 |
6 | Acquisition by Auerbach Michael of 64000 shares of ATAI Life subject to Rule 16b-3 | 01/24/2025 |
7 | atai Life Sciences Announces Positive Topline Results from Beckley Psytechs BPL-003 ... | 01/28/2025 |
8 | Psychedelic atai Life Sciences reports BPL-003 study results - TipRanks | 01/30/2025 |
9 | atai Life Sciences Announces Proposed Public Offering of Common Shares | 02/12/2025 |
10 | atai Life Sciences Announces Pricing of Public Offering of Common Shares | 02/13/2025 |
11 | Acquisition by Apeiron Investment Group Ltd. of 10835718 shares of ATAI Life at 2.1 subject to Rule 16b-3 | 02/14/2025 |
12 | atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase ... | 02/20/2025 |
13 | Acquisition by Florian Brand of 20000 shares of ATAI Life at 1.156 subject to Rule 16b-3 | 02/21/2025 |
14 | atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference | 02/24/2025 |
Begin Period Cash Flow | 190.6 M |
ATAI |
ATAI Life Relative Risk vs. Return Landscape
If you would invest 163.00 in ATAI Life Sciences on December 3, 2024 and sell it today you would earn a total of 9.00 from holding ATAI Life Sciences or generate 5.52% return on investment over 90 days. ATAI Life Sciences is currently generating 0.3278% in daily expected returns and assumes 7.0979% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than ATAI, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
ATAI Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATAI Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ATAI Life Sciences, and traders can use it to determine the average amount a ATAI Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0462
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ATAI | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.1 actual daily | 63 63% of assets are less volatile |
Expected Return
0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average ATAI Life is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATAI Life by adding it to a well-diversified portfolio.
ATAI Life Fundamentals Growth
ATAI Stock prices reflect investors' perceptions of the future prospects and financial health of ATAI Life, and ATAI Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ATAI Stock performance.
Return On Equity | -0.63 | ||||
Return On Asset | -0.26 | ||||
Operating Margin | (565.05) % | ||||
Current Valuation | 270.58 M | ||||
Shares Outstanding | 193.99 M | ||||
Price To Earning | 0.30 X | ||||
Price To Book | 2.28 X | ||||
Price To Sales | 1,008 X | ||||
Revenue | 314 K | ||||
Gross Profit | 331 K | ||||
EBITDA | (36.31 M) | ||||
Net Income | (40.22 M) | ||||
Cash And Equivalents | 304.06 M | ||||
Cash Per Share | 1.83 X | ||||
Total Debt | 19.14 M | ||||
Debt To Equity | 0.06 % | ||||
Current Ratio | 12.25 X | ||||
Book Value Per Share | 0.87 X | ||||
Cash Flow From Operations | (84.12 M) | ||||
Earnings Per Share | (0.80) X | ||||
Market Capitalization | 333.67 M | ||||
Total Asset | 293.48 M | ||||
Retained Earnings | (550.94 M) | ||||
Working Capital | 165.47 M | ||||
Current Asset | 320.15 M | ||||
Current Liabilities | 74.35 M | ||||
About ATAI Life Performance
By evaluating ATAI Life's fundamental ratios, stakeholders can gain valuable insights into ATAI Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ATAI Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ATAI Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | -14.1 K | -13.4 K | |
Return On Tangible Assets | (0.12) | (0.13) | |
Return On Capital Employed | (0.53) | (0.55) | |
Return On Assets | (0.12) | (0.13) | |
Return On Equity | (0.15) | (0.16) |
Things to note about ATAI Life Sciences performance evaluation
Checking the ongoing alerts about ATAI Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ATAI Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.ATAI Life Sciences had very high historical volatility over the last 90 days | |
ATAI Life Sciences may become a speculative penny stock | |
The company reported the previous year's revenue of 314 K. Net Loss for the year was (40.22 M) with profit before overhead, payroll, taxes, and interest of 331 K. | |
ATAI Life Sciences currently holds about 304.06 M in cash with (84.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
ATAI Life Sciences has a frail financial position based on the latest SEC disclosures | |
Latest headline from gurufocus.com: atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference |
- Analyzing ATAI Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ATAI Life's stock is overvalued or undervalued compared to its peers.
- Examining ATAI Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ATAI Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ATAI Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ATAI Life's stock. These opinions can provide insight into ATAI Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ATAI Stock analysis
When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |